European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Dermatological drug tenders in Spain

Dermatological drug tenders in Spain: 70 listed on GranTender since 2024; none is open now. The median awarded contract value is about €8,200 (209 contracts with a stated value). Buyers with the most tenders: Gerencia de Atención Primaria del Area de Salud de Tenerife (15), Consorci Hospitalari de Vic (8) and Instituto Murciano Investigación y Desarrollo Agrario y Alimentario (IMIDA) (4); suppliers with the most contract awards: Laboratorios Normon, S.A. (54), B. Braun Medical, S.A. (12) and Mape Asesores, S.A. (11). Sources: PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED. In 2025 the median contract value was €12,000; 41% of contracts drew a single bid (2.6 bids on average). Data as of 18 November 2026; updated daily.

Tenders
70
Open tenders
0
Awards
283
Awarded value awarded
€20,851,647
Awarded value framework ceiling
€8,618,095
Median contract value awarded
≈ €8,200
Median contract value framework ceiling
≈ €160,000
Average bids per contract
2.3
Tenders in 2025
20 -50% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

No records yet.

Latest tenders

TenderBuyerEstimated valueStatusPublished
Suministro farmacéutico del principio activo Toxina Botulínica Tipo A para la Gerencia de Servicios Sanitarios del Área de Salud de Fuerteventura.Gerencia de Atención Primaria del Area de Salud de Tenerife€475,200Awarded6 November 2026
Suministro de Ácido Hialurónico para los Centros asistenciales y Hospitales de ASEPEYOSubdirección General Sanitaria de ASEPEYO. Mutua Colaboradora con la Seguridad Social. num. 151€222,300Closed8 October 2026
Dexketoprofeno 50 mg, solución inyectable y para perfusión, en ampollaGerencia de Atención Primaria del Area de Salud de Tenerife€36,000Closed30 September 2026
Suministro de diversas especialidades farmacéuticas con destino al servicio de farmacia del hospital de MAZ M.C.S.S. Nº11.Gerencia de MAZ Mútua de Accidentes de Trabajo y Enfermedades Profesionales de la Seguridad Social nº 11€839,016Awarded6 July 2026
Productes de cura i prevenció de lesions per pressióConsorcio Corporació Sanitària Parc Taulí de Sabadell€1,621,456Awarded30 March 2026
suministro de medicamentos exclusivos con principios activos carbidopa/entacapona/levodopa gel intestinal, centella asiatica pomada, elexacaftor/ivacaftor/tezacaftor, ivacaftor, maiz/zinc, mexiletina, nelarabina, oxibuprocaina/tetracaina colirio, teclistamab y tropicamida colirio de los laboratorios farmacéuticos alcon healthcare, s.a., almirall s.a., bexal farmaceutica, s.a., exeltis healthcare,Servicio Murciano de Salud - Gerencia€59,796,734Awarded10 December 2025
Subministrament de productes per tractament de ferides amb destí a la Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant PauFundació de Gestió Sanitària de l'Hospital de la Santa Creu i Sant Pau€1,946,484Awarded4 August 2025
Suministro de diversas especialidades farmacéuticas con destino al Servicio de Farmacia del Hospital MAZ MCSS nº 11 en ZaragozaGerencia de MAZ Mútua de Accidentes de Trabajo y Enfermedades Profesionales de la Seguridad Social nº 11€885,654Cancelled29 July 2025
Suministro de Ácido hialurónico con destino a los centros de umivale ActivaGerencia umivale Activa, Mutua Colaboradora con la Seguridad Social número 3€210,000Awarded26 June 2025
Suministro del medicamento IvermectinaDirección General de Salud Pública, Consumo y Cuidados, Consejería de Salud y Políticas Sociales€29,427Awarded29 October 2024
Suministro de medicamentos con principios activos cisatracurio 2 mg/ml, dexketoprofeno parenteral, fentanilo parenteral, flumazenil, hierro sacarosa, lacosamida parenteral, levosimendan, norepinefrina, paliperidona intramuscular mensual, paracetamol 1000 mg parenteral, propofol 2%, propofol 1%, rocuronio, sugammadex, toxina botulinica tipo a 50 unidades, toxina botulinica tipo a 100 unidades y toxServicio Murciano de Salud - Gerencia€15,858,027Awarded28 October 2024
Suministro de kits de inyección intravítea para el Hospital Universitario de BellvitgeHospital Universitario de Bellvitge€308,750Closed22 July 2024
Suministro de SOLUCION DIMETIL ETER+PROPANO P/CRIOTERAPIA con destino a los centros de salud dependientes de la Gerencia Asistencial de Atención Primaria.Gerencia Asistencial Atención Primaria - SERMAS€142,666Awarded23 May 2024
SUMINISTRO DE MEDICAMENTOS CON PRINCIPIOS ACTIVOS CISATRACURIO 2 MG/ML, DEXKETOPROFENO PARENTERAL, FENTANILO PARENTERAL, FLUMAZENIL, HIERRO SACAROSA, LACOSAMIDA PARENTERAL, LEVOSIMENDAN, NOREPINEFRINA, PALIPERIDONA INTRAMUSCULAR MENSUAL, PARACETAMOL 1000 MG PARENTERAL, PROPOFOL 2%, PROPOFOL 1%, ROCURONIO, SUGAMMADEX, TOXINA BOTULINICA TIPO A 50 UNIDADES, TOXINA BOTULINICA TIPO A 100 UNIDADES Y TOXServicio Murciano de Salud - Gerencia€15,858,027Awarded25 March 2024

Competition and prices

In 2025, half of the contracts were worth between €3,100 and €37,000, with a median of €12,000 (89 contracts with a stated awarded value). Contracts drew 2.6 bids on average (median 2) and 41% drew a single bid — based on 63 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 64% and the share of single-bid contracts rose from 39% to 41%. The usual procedures: direct award (46%), open procedure (41%), other procedures (4%) — of 56 tenders with a stated procedure.

The most contracts went to Laboratorios Normon, S.A. (54), B. Braun Medical, S.A. (12) and Mape Asesores, S.A. (11) — together 27% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2024123€7,300€210 – €97,0002.239% (108)
202589€12,000€3,100 – €37,0002.641% (63)
2026 (so far)25€17,000€6,100 – €27,0002.064% (22)
All years239€12,000€2,300 – €39,0002.343% (195)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 47% of the 85 contracts with a known number of bids had a single bid; the median was 2 bids. The number of bids is known for 85 of the 93 contracts from procedures with competition.

Buyers who often get few offers

The buyers below usually received one or two offers per contract — an offer from you would stand out.

In the last 12 months, 0 companies won their first contract in our records here — 0% of the 64 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33630000 Medicinal products for dermatology and the musculo-skeletal system

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Dermatological and musculoskeletal drugs in neighbouring countries

No tender in the same niche is open today in neighbouring countries; 3,069 were published there since 2024.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon2

ExpectedBuyerWhatWhy we expect itConfidence
now – Dec 2026
every year
Servicio Murciano de Salud - GerenciaDermatological and musculoskeletal drugs
suministro de medicamentos exclusivos con principios activos carbidopa/entacapona/levodopa gel intestinal, centella asiatica pomada, elexacaftor/ivacaftor/tezacaftor, ivacaftor, maiz/zinc, mexiletina, nelarabina, oxibuprocaina/tetracaina colirio, teclistamab y tropicamida colirio de los laboratorios farmacéuticos alcon healthcare, s.a., almirall s.a., bexal farmaceutica, s.a., exeltis healthcare,
Typical value: ≈ €16m
The buyer has published dermatological drug tenders every year in November since 2024.
Earlier tenders: 12/2025, 10/2024
medium
Jan – Jun 2027
contract ends
Fundació de Gestió Sanitària de l'Hospital de la Santa Creu i Sant PauDermatological and musculoskeletal drugs
Subministrament de productes per tractament de ferides amb destí a la Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau
Typical value: ≈ €14,000
The current contract with CONVATEC, S.L. ends on 29 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 08/2025
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Dermatological and musculoskeletal drugs by city

Dermatological and musculoskeletal drugs in other countries

Dermatological and musculoskeletal drugs across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which dermatological drug tenders in Spain are open now?
None is open at the moment; GranTender lists 70 in total.
Where can I find dermatological drug tenders in Spain?
GranTender lists them in one place, from PLACSP, Registre públic de contractes de Catalunya (RPC) — Catalan public contracts register, open data (Generalitat) and TED, with their buyers, winners and contract values; 0 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most dermatological drug tenders in Spain?
By number of contracts won: Laboratorios Normon, S.A. (54), B. Braun Medical, S.A. (12), Mape Asesores, S.A. (11).
Which buyers publish the most dermatological drug tenders in Spain?
By number of tenders: Gerencia de Atención Primaria del Area de Salud de Tenerife (15), Consorci Hospitalari de Vic (8), Instituto Murciano Investigación y Desarrollo Agrario y Alimentario (IMIDA) (4).
Which CPV codes belong to “Dermatological and musculoskeletal drugs”?
33630000 Medicinal products for dermatology and the musculo-skeletal system; plus tenders without a usable CPV code whose title names the topic.
How many bids do dermatological drug tenders in Spain receive on average?
In 2025, contracts drew 2.6 bids on average (median 2) and 41% drew a single bid — based on 63 contracts with a known number of bids.
How much are contracts for dermatological drug tenders in Spain worth?
In 2025, half of the contracts were worth between €3,100 and €37,000, with a median of €12,000 (89 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 64% and the share of single-bid contracts rose from 39% to 41%.
Which procedures are used for dermatological drug tenders in Spain?
The usual procedures: direct award (46%), open procedure (41%), other procedures (4%) — of 56 tenders with a stated procedure.
Which buyers get few offers in dermatological drug tenders in Spain?
Since 1 November 2024, these buyers usually received one or two offers per contract: Gerencia de MAZ Mútua de Accidentes de Trabajo y Enfermedades Profesionales de la Seguridad Social nº 11 (median 1 bid over 38 contracts) and Consorcio Corporació Sanitària Parc Taulí de Sabadell (median 1 bid over 22 contracts). Since 1 November 2024, 47% of the 85 contracts with a known number of bids had a single bid; the median was 2 bids.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.